Codes / ICD10CM / M06.379

M06.379 Rheumatoid nodule, unspecified ankle and foot

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid nodule, unspecified ankle and foot

Summary

Rheumatoid nodule, unspecified ankle and foot, is a localized extra-articular manifestation of rheumatoid arthritis (RA) involving firm, subcutaneous nodules in the ankle or foot region. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. They are associated with severe, long-standing RA, particularly in patients with high rheumatoid factor or anti-CCP antibody levels. The exact pathogenesis involves dysregulated immune responses and fibroblast activation, leading to nodule formation. They may also develop at sites of trauma or injection.

Risk Factors

  • Severe, long-standing rheumatoid arthritis (especially seropositive disease).
  • High rheumatoid factor or anti-CCP antibody titers.
  • Presence of other extra-articular RA manifestations (e.g., vasculitis).
  • Chronic inflammation and immune dysregulation.
  • Trauma or pressure to affected areas.

Symptoms

  • Firm, movable subcutaneous nodules in the ankle or foot area.
  • Nodules may be painless or tender.
  • May be associated with underlying joint inflammation or deformity.

Diagnosis

Diagnosis is primarily clinical, based on the presence of firm subcutaneous nodules in the ankle or foot region and correlation with a history of rheumatoid arthritis. Imaging (e.g., ultrasound or MRI) may be used to confirm the presence of nodules and rule out other conditions. Laboratory tests for rheumatoid factor or anti-CCP antibodies may support the diagnosis but are not definitive for nodules alone.

Treatment Options

Treatment focuses on managing underlying rheumatoid arthritis, as nodules often improve with disease control. Options include disease-modifying antirheumatic drugs (DMARDs), biologic agents, or targeted synthetic DMARDs. Local measures, such as padding or steroid injections, may alleviate discomfort. Surgical removal is rarely needed unless nodules cause functional impairment or ulceration.

Prognosis and Follow-Up

Prognosis depends on the severity of underlying RA. Nodules may persist or fluctuate with disease activity. Regular follow-up with a rheumatologist is recommended to monitor RA progression and adjust treatment. Nodule size or number may decrease with effective RA management.

Complications

  • Ulceration or infection if nodules erode the skin.
  • Functional impairment due to pressure on tendons or nerves.
  • Psychosocial impact from visible nodules.

Lifestyle & Prevention

  • Maintain optimal RA control through medication adherence.
  • Avoid trauma or excessive pressure to affected areas.
  • Use supportive footwear to reduce foot pressure.
  • Monitor for skin changes and report new or worsening nodules promptly.

When to Seek Professional Help

Seek medical attention if nodules become painful, ulcerate, increase in size, or interfere with movement. Prompt evaluation is also recommended if new joint symptoms or systemic RA flares occur.

Tips for Medical Coders

Code M06.379 is specific to rheumatoid nodules in the unspecified ankle and foot. Documentation should specify the location (unspecified ankle/foot) and confirm the association with rheumatoid arthritis. Ensure clinical correlation with RA diagnosis and exclude other causes of subcutaneous nodules.

Book a walkthrough

M06.379 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.